Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Sponsor: The Foundation for Barnes-Jewish Hospital
Terminated
Loss of funding and slow enrollment
Other terminated trials from The Foundation for Barnes-Jewish Hospital
See all terminations from The Foundation for Barnes-Jewish Hospital
A NA clinical study on Hereditary Breast and Ovarian Cancer and Lynch Syndrome, this trial is terminated or withdrawn. The trial is conducted by The Foundation for Barnes-Jewish Hospital and has accumulated 14 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2024 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2024 — May 2024 [monthly]
Recruiting NA
▶ Show 9 earlier versions
-
Jul 2023 — Jan 2024 [monthly]
Recruiting NA
-
Jan 2023 — Jul 2023 [monthly]
Recruiting NA
-
Jul 2022 — Jan 2023 [monthly]
Recruiting NA
-
Nov 2021 — Jul 2022 [monthly]
Recruiting NA
-
May 2021 — Nov 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — May 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Sep 2020 — Nov 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The Foundation for Barnes-Jewish Hospital
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .